Skip to main content

Advertisement

SpringerLink
Log in

Exogenous Melatonin for Delirium Prevention: a Meta-analysis of Randomized Controlled Trials

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Recently, two high-quality clinical randomized controlled trials (RCTs) regarding the preventive effect of exogenous melatonin on delirium drew inconsistent conclusions. We therefore performed a systemic review to explore whether melatonin had a benefit on delirium prevention. MEDLINE, EMBASE, and Cochrane Library were searched from January 1980 to April 2015 for English language studies. After strict selection and evaluation, the data were extracted from the included four RCTs. The primary outcome of this meta-analysis was the incidence of delirium. The secondary outcome was the improvement of sleep–wake rhythm. A total of four RCTs with 669 elderly patients were included in the present study. Melatonin group showed a tendency to decrease the incidence of delirium (relative risk [RR] 0.41, 95 % confidence interval [CI] 0.15 to 1.13; P = 0.08) compared with control group. In subgroup analysis of the elderly patients in medical wards, melatonin supplementation decreased the incidence of delirium by 75 % (RR 0.25, 95 % CI 0.07 to 0.88; P = 0.03), but not in sleep–wake disturbance (RR 1.24, 95 % CI 0.51 to 3.00; P = 0.64). No differences were found in the incidence of delirium between the two groups in the elderly patients that were presented to surgical wards. In conclusion, melatonin supplementation had a significant preventive effect in decreasing the incidence of delirium in elderly patients that were presented to medical wards. Further studies should provide sufficient evidence about the effect of melatonin on delirium in a large sample size.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References:

  1. Gray SL, Lai KV, Larson EB (1999) Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 21(2):101–122. doi:10.2165/00002018-199921020-00004

    Article  CAS  PubMed  Google Scholar 

  2. de Jonghe A, Korevaar JC, van Munster BC, de Rooij SE (2010) Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review. Int J Geriatr Psychiatr 25(12):1201–1208. doi:10.1002/gps.2454

    Article  Google Scholar 

  3. Kiely DK, Marcantonio ER, Inouye SK, Shaffer ML, Bergmann MA, Yang FM, Fearing MA, Jones RN (2009) Persistent delirium predicts greater mortality. J Am Geriatr Soc 57(1):55–61. doi:10.1111/j.1532-5415.2008.02092.x

    Article  PubMed  PubMed Central  Google Scholar 

  4. Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK (2008) One-year health care costs associated with delirium in the elderly population. Arch Intern Med 168(1):27–32. doi:10.1001/archinternmed.2007.4

    Article  PubMed  PubMed Central  Google Scholar 

  5. Friedman JI, Soleimani L, McGonigle DP, Egol C, Silverstein JH (2014) Pharmacological treatments of non-substance-withdrawal delirium: a systematic review of prospective trials. Am J Psychiatry 171(2):151–159. doi:10.1176/appi.ajp.2013.13040458

    Article  PubMed  Google Scholar 

  6. de Rooij SE, van Munster BC, de Jonghe A (2014) Melatonin prophylaxis in delirium: panacea or paradigm shift? JAMA Psychiatry 71(4):364–365. doi:10.1001/jamapsychiatry.2013.4532

    Article  PubMed  Google Scholar 

  7. Pandi-Perumal SR, Srinivasan V, Spence DW, Cardinali DP (2007) Role of the melatonin system in the control of sleep: therapeutic implications. CNS Drugs 21(12):995–1018. doi:10.2165/00023210-200721120-00004

    Article  CAS  PubMed  Google Scholar 

  8. Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM, Reiter RJ (2003) Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 34(1):75–78. doi:10.1034/j.1600-079X.2003.02111.x

    Article  CAS  PubMed  Google Scholar 

  9. Fukada Y, Okano T (2002) Circadian clock system in the pineal gland. Mol Neurobiol 25(1):19–30. doi:10.1385/mn:25:1:019

    Article  CAS  PubMed  Google Scholar 

  10. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Shenkman L (2000) Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int 17(1):71–76. doi:10.1081/CBI-100101033

    Article  CAS  PubMed  Google Scholar 

  11. Cronin AJ, Keifer JC, Davies MF, King TS, Bixler EO (2000) Melatonin secretion after surgery. Lancet 356(9237):1244–1245. doi:10.1016/S0140-6736(00)02795-1

    Article  CAS  PubMed  Google Scholar 

  12. Miyazaki T, Kuwano H, Kato H, Ando H, Kimura H, Inose T, Ohno T, Suzuki M et al (2003) Correlation between serum melatonin circadian rhythm and intensive care unit psychosis after thoracic esophagectomy. Surgery 133(6):662–668. doi:10.1067/msy.2003.149

    Article  PubMed  Google Scholar 

  13. Mistraletti G, Sabbatini G, Taverna M, Figini MA, Umbrello M, Magni P, Ruscica M, Dozio E et al (2010) Pharmacokinetics of orally administered melatonin in critically ill patients. J Pineal Res 48(2):142–147. doi:10.1111/j.1600-079X.2009.00737.x

    Article  CAS  PubMed  Google Scholar 

  14. Yoshitaka S, Egi M, Morimatsu H, Kanazawa T, Toda Y, Morita K (2013) Perioperative plasma melatonin concentration in postoperative critically ill patients: its association with delirium. J Crit Care 28(3):236–242. doi:10.1016/j.jcrc.2012.11.004

    Article  CAS  PubMed  Google Scholar 

  15. Magri F, Sarra S, Cinchetti W, Guazzoni V, Fioravanti M, Cravello L, Ferrari E (2004) Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians. J Pineal Res 36(4):256–261. doi:10.1111/j.1600-079X.2004.00125.x

    Article  CAS  PubMed  Google Scholar 

  16. Kennaway DJ, Lushington K, Dawson D, Lack L, van den Heuvel C, Rogers N (1999) Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature. J Pineal Res 27(4):210–220. doi:10.1111/j.1600-079X.1999.tb00617.x

    Article  CAS  PubMed  Google Scholar 

  17. Balan S, Leibovitz A, Zila SO, Ruth M, Chana W, Yassica B, Rahel B, Richard G et al (2003) The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatr Clin Neurosci 15(3):363–366. doi:10.1176/appi.neuropsych.15.3.363

    Article  Google Scholar 

  18. Mahlberg R, Tilmann A, Salewski L, Kunz D (2006) Normative data on the daily profile of urinary 6-sulfatoxymelatonin in healthy subjects between the ages of 20 and 84. Psychoneuroendocrinology 31(5):634–641. doi:10.1016/j.psyneuen.2006.01.009

    Article  CAS  PubMed  Google Scholar 

  19. Fitzgerald JM, Adamis D, Trzepacz PT, O'Regan N, Timmons S, Dunne C, Meagher DJ (2013) Delirium: a disturbance of circadian integrity? Med Hypotheses 81(4):568–576. doi:10.1016/j.mehy.2013.06.032

    Article  PubMed  Google Scholar 

  20. Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S et al (2005) Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology 48(2):301–310. doi:10.1016/j.neuropharm.2004.09.007

    Article  CAS  PubMed  Google Scholar 

  21. Wurtman R (2006) Ramelteon: a novel treatment for the treatment of insomnia. Expert Rev Neurother 6(7):957–964. doi:10.1586/14737175.6.7.957

    Article  CAS  PubMed  Google Scholar 

  22. Hanania M, Kitain E (2002) Melatonin for treatment and prevention of postoperative delirium. Anesth Analg 94((2):338–339, table of contents

    PubMed  Google Scholar 

  23. Lammers M, Ahmed AI (2013) Melatonin for sundown syndrome and delirium in dementia: is it effective? J Am Geriatr Soc 61(6):1045–1046. doi:10.1111/jgs.12296

    Article  PubMed  Google Scholar 

  24. Kimura R, Mori K, Kumazaki H, Yanagida M, Taguchi S, Matsunaga H (2011) Treatment of delirium with ramelteon: initial experience in three patients. Gen Hosp Psychiatry 33(4):407–409. doi:10.1016/j.genhosppsych.2011.03.013

    Article  PubMed  Google Scholar 

  25. Furuya M, Miyaoka T, Yasuda H, Yamashita S, Tanaka I, Otsuka S, Wake R, Horiguchi J (2012) Marked improvement in delirium with ramelteon: five case reports. Psychogeriatr: Off J Jpn Psychogeriatr Soc 12(4):259–262. doi:10.1111/j.1479-8301.2012.00422.x

    Article  Google Scholar 

  26. Ohta T, Murao K, Miyake K, Takemoto K (2013) Melatonin receptor agonists for treating delirium in elderly patients with acute stroke. J Stroke Cerebrovas Dis: Off J Natl Stroke Assoc 22(7):1107–1110. doi:10.1016/j.jstrokecerebrovasdis.2012.08.012

    Article  Google Scholar 

  27. Tsuda A, Nishimura K, Naganawa E, Otsubo T, Ishigooka J (2013) Successfully treated delirium in an extremely elderly patient by switching from risperidone to ramelteon. Psychiatry Clin Neurosci 67(2):130. doi:10.1111/pcn.12016

    Article  PubMed  Google Scholar 

  28. Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Nakamura H (2014) Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry 71(4):397–403. doi:10.1001/jamapsychiatry.2013.3320

    Article  CAS  PubMed  Google Scholar 

  29. de Jonghe A, van Munster BC, Goslings JC, Kloen P, van Rees C, Wolvius R, van Velde R, Levi M et al (2014) Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial. CMAJ: Can Med Assoc J 186(14):E547–E556. doi:10.1503/cmaj.140495

    Article  Google Scholar 

  30. Al-Aama T, Brymer C, Gutmanis I, Woolmore-Goodwin SM, Esbaugh J, Dasgupta M (2011) Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry 26(7):687–694. doi:10.1002/gps.2582

    Article  PubMed  Google Scholar 

  31. Sultan SS (2010) Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly. Saudi J Anaesth 4(3):169–173. doi:10.4103/1658-354x.71132

    Article  PubMed  PubMed Central  Google Scholar 

  32. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. doi:10.1136/bmj.b2700

    Article  PubMed  PubMed Central  Google Scholar 

  33. Shi L, Pu J, Xu L, Malaguit J, Zhang J, Chen S (2014) The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis. BMC Neurol 14(1):251. doi:10.1186/s12883-014-0251-7

    Article  PubMed  PubMed Central  Google Scholar 

  34. Parikh SS, Chung F (1995) Postoperative delirium in the elderly. Anesth Analg 80(6):1223–1232

    CAS  PubMed  Google Scholar 

  35. de Rooij SE, van Munster BC (2013) Melatonin deficiency hypothesis in delirium: a synthesis of current evidence. Rejuvenation Res 16(4):273–278. doi:10.1089/rej.2012.1405

    Article  PubMed  Google Scholar 

  36. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9(1):41–50. doi:10.1016/j.smrv.2004.06.004

    Article  PubMed  Google Scholar 

  37. Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP et al (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 332(7538):385–393. doi:10.1136/bmj.38731.532766.F6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Liu J, Wang LN (2012) Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. Int J Clin Pract 66(9):867–873. doi:10.1111/j.1742-1241.2012.02987.x

    Article  CAS  PubMed  Google Scholar 

  39. Kuriyama A, Honda M, Hayashino Y (2014) Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Med 15(4):385–392. doi:10.1016/j.sleep.2013.11.788

    Article  PubMed  Google Scholar 

  40. Maldonado JR (2008) Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin 24(4):789–856. doi:10.1016/j.ccc.2008.06.004, ix

    Article  CAS  PubMed  Google Scholar 

  41. Zisapel N, Laudon M (1982) Dopamine release induced by electrical field stimulation of rat hypothalamus in vitro: inhibition by melatonin. Biochem Biophys Res Commun 104(4):1610–1616

    Article  CAS  PubMed  Google Scholar 

  42. Maclullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C (2008) Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 65(3):229–238. doi:10.1016/j.jpsychores.2008.05.019

    Article  PubMed  PubMed Central  Google Scholar 

  43. Garcia JJ, Lopez-Pingarron L, Almeida-Souza P, Tres A, Escudero P, Garcia-Gil FA, Tan DX, Reiter RJ et al (2014) Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res 56(3):225–237. doi:10.1111/jpi.12128

    Article  CAS  PubMed  Google Scholar 

  44. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36(1):1–9. doi:10.1046/j.1600-079X.2003.00092.x

    Article  CAS  PubMed  Google Scholar 

  45. Alzoubi KH, Mayyas FA, Khabour OF, Bani Salama FM, Alhashimi FH, Mhaidat NM (2015) Chronic Melatonin Treatment Prevents Memory Impairment Induced by Chronic Sleep Deprivation. Mol Neurobiol. doi:10.1007/s12035-015-9286-z

    PubMed  Google Scholar 

  46. Joshi N, Biswas J, Nath C, Singh S (2014) Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology. Mol Neurobiol. doi:10.1007/s12035-014-8865-8

    Google Scholar 

  47. Ni Chonchubhair A, Valacio R, Kelly J, O'Keefe S (1995) Use of the abbreviated mental test to detect postoperative delirium in elderly people. Br J Anaesth 75(4):481–482

    Article  CAS  PubMed  Google Scholar 

  48. Hare M, Wynaden D, McGowan S, Speed G (2008) Assessing cognition in elderly patients presenting to the emergency department. Int Emerg Nurs 16(2):73–79. doi:10.1016/j.ienj.2008.01.005

    Article  PubMed  Google Scholar 

  49. Jitapunkul S, Pillay I, Ebrahim S (1991) The abbreviated mental test: its use and validity. Age Ageing 20(5):332–336. doi:10.1093/ageing/20.5.332

    Article  CAS  PubMed  Google Scholar 

  50. Vural EM, van Munster BC, de Rooij SE (2014) Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature. Drugs Aging 31(6):441–451. doi:10.1007/s40266-014-0178-0

    Article  CAS  PubMed  Google Scholar 

  51. Koch BC, Nagtegaal JE, Kerkhof GA, ter Wee PM (2009) Circadian sleep-wake rhythm disturbances in end-stage renal disease. Nat Rev Nephrol 5(7):407–416. doi:10.1038/nrneph.2009.88

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by National Natural Science Foundation of China (No. 81171096 and No. 81371433) to JM Zhang and National Natural Science Foundation of China (No. 81271273) to Q Wu.

Conflict of interest

The authors report no financial or other relationship relevant to the subject of this article.

Author information

Author notes

    Authors and Affiliations

    1. Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China

      Sheng Chen, LiGen Shi, Feng Liang, Liang Xu, Qun Wu & Jianmin Zhang

    2. Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, USA

      Doycheva Desislava

    Authors
    1. Sheng Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. LiGen Shi
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Feng Liang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Liang Xu
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Doycheva Desislava
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Qun Wu
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Jianmin Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Qun Wu.

    Additional information

    Sheng Chen and LiGen Shi contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Chen, S., Shi, L., Liang, F. et al. Exogenous Melatonin for Delirium Prevention: a Meta-analysis of Randomized Controlled Trials. Mol Neurobiol 53, 4046–4053 (2016). https://doi.org/10.1007/s12035-015-9350-8

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12035-015-9350-8

    Keywords

    Search

    Navigation